Clinical significance of Beta-2 glycoprotein I antibodies in BcrAbl (-) myeloproliferative neoplasms
Department of Hematology, Faculty of Medicine
Biography:
Mehmet Dagli is currently working in the Department of Haematology, Faculty of Medicine, Selcuk University, Konya, Turkey. One of research work is Determination of serum imatinib and its' metabolite in patients chronic myeloid leukemia
Subjects of specialization: Policythaemia vera, Essential thrombocytosis, Thrombosis, The ratio of neutrophil/lymphocyte